Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02953509
Title Trial of Hu5F9-G4 in Combination With Rituximab in Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Forty Seven, Inc.

marginal zone B-cell lymphoma

diffuse large B-cell lymphoma

follicular lymphoma

non-Hodgkin lymphoma


Hu5F9-G4 + Rituximab

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.